Format

Send to

Choose Destination
Skin Appendage Disord. 2015 Sep;1(2):74-81. doi: 10.1159/000433473. Epub 2015 Jun 26.

Network Meta-Analysis of Onychomycosis Treatments.

Author information

1
Department of Medicine, University of Toronto, Toronto, Ont., Canada; Mediprobe Research Inc., London, Ont., Canada.
2
Mediprobe Research Inc., London, Ont., Canada.

Abstract

BACKGROUND:

Many onychomycosis treatments have not been directly compared in head-to-head clinical trials.

OBJECTIVE:

To determine the relative efficacy of onychomycosis treatments using network meta-analysis (NMA).

METHODS:

We conducted a systematic review and NMA of mycological cure rates.

RESULTS:

Nineteen trials were included in the network. Terbinafine 250 mg was significantly superior to all treatments except itraconazole 400 mg pulse therapy. The itraconazole 400 mg pulse regimen was significantly superior to all topicals except efinaconazole 10% nail solution. Itraconazole 200 mg was significantly superior to all topical treatments, while fluconazole 150-450 mg, efinaconazole 10% nail solution, tavaborole 5% nail solution, ciclopirox nail lacquer 8%, terbinafine nail solution, and amorolfine 5% nail lacquer were significantly superior to placebo.

CONCLUSIONS:

Newly developed topicals have improved the odds ratios (ORs) of mycological cure, yet these ORs were not significantly greater than preexisting topical treatments. Further experience with these agents will reveal their clinical significance, and head-to-head trials are warranted. © 2015 S. Karger AG, Basel.

KEYWORDS:

Antifungals; Network meta-analysis; Onychomycosis; Systematic review

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center